These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 18794658

  • 1. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD, Hake L, Benjamin AB, Adityanjee A.
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract] [Full Text] [Related]

  • 2. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Oct; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 3. Long-acting risperidone-induced periorbital edema.
    Pelizza L.
    J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
    [No Abstract] [Full Text] [Related]

  • 4. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S.
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract] [Full Text] [Related]

  • 5. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    Uzun S, Kozumplik O, Jakovljević M, Folnegović-Smalc V.
    J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
    [No Abstract] [Full Text] [Related]

  • 6. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH, Yang P, Yen JY, Chen CC, Yang MJ.
    Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
    [Abstract] [Full Text] [Related]

  • 7. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T, Fujii Y, Misawa F.
    J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
    [No Abstract] [Full Text] [Related]

  • 10. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED, Stimmel GL.
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [Abstract] [Full Text] [Related]

  • 11. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 12. Dantrolene in lethal catatonia.
    Pennati A, Sacchetti E, Calzeroni A.
    Am J Psychiatry; 1991 Feb; 148(2):268. PubMed ID: 1670981
    [No Abstract] [Full Text] [Related]

  • 13. Caution is still needed when prescribing atypical antipsychotics.
    Carey S.
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome with risperidone.
    Gleason PP, Conigliaro RL.
    Pharmacotherapy; 1997 May; 17(3):617-21. PubMed ID: 9165568
    [Abstract] [Full Text] [Related]

  • 15. Long-acting injectable risperidone.
    Ehret MJ, Fuller MA.
    Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979
    [Abstract] [Full Text] [Related]

  • 16. Long-acting risperidone and oral antipsychotics in unstable schizophrenia.
    Rosenheck RA, Krystal JH, Lew R, Barnett PG, Fiore L, Valley D, Thwin SS, Vertrees JE, Liang MH, CSP555 Research Group.
    N Engl J Med; 2011 Mar 03; 364(9):842-51. PubMed ID: 21366475
    [Abstract] [Full Text] [Related]

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 03; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 18. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T, Westendorp RG.
    Ned Tijdschr Geneeskd; 2005 Mar 12; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK, Bos F, Vorel-Havelkova E, Brombacher PJ.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract] [Full Text] [Related]

  • 20. Follow-up of a pregnancy with risperidone microspheres.
    Dabbert D, Heinze M.
    Pharmacopsychiatry; 2006 Nov 15; 39(6):235. PubMed ID: 17124649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.